TMS therapy marketing for the patients medication has not helped.

What is TMS therapy marketing?

It is the work of helping the right people find a TMS clinic, understand whether TMS fits them, and book an evaluation. The National Institute of Mental Health describes the treatment this way: Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive therapy that uses an electromagnet to stimulate the brain using repeated low-intensity pulses. (NIMH, Brain Stimulation Therapies, last reviewed March 2024.)

People are looking for it. In the United States, "tms therapy" is searched about 90,500 times a month, up 22% on a year earlier, and "tms therapy near me" about 12,100 times (Google Keyword Planner, US, average monthly searches October 2025 to September 2026, read October 28, 2026).

TMS marketing is different from most clinic marketing for three reasons, all of them written into the source documents:

• It usually comes after medication. FDA's December 2008 clearance of the NeuroStar TMS Therapy System covers adults who have failed to achieve satisfactory improvement from one prior antidepressant medication in the current episode.
• Coverage has conditions. In the Medicare region Novitas runs (11 states and Washington, D.C., including Texas, Pennsylvania and New Jersey), TMS for severe major depression is covered for up to six weeks when medication has failed or was not tolerated and a psychiatrist who examined the patient writes the order; other conditions apply.
• The ad rules treat it as sensitive health. Neither Google nor Meta has a TMS rule of its own that we could find; TMS falls under their general health rules, covered below.

So a TMS plan has two jobs: reach people who may qualify, and explain fit and coverage plainly enough that the calls you get are the right ones. TMS sits inside the behavioral health work on our addiction and mental health marketing hub.

What is TMS FDA-cleared to treat?

Specific TMS devices are FDA-cleared or granted for uses including major depressive disorder in adults (since 2008), as an adjunct for obsessive-compulsive disorder (2018), as an aid in short-term smoking cessation (2020), for major depressive disorder in adults on an accelerated schedule (2022) and as an adjunct for major depressive disorder in patients aged 15 to 21 (2024). The National Institute of Mental Health's list also includes migraines and anxiety with depression. Clearances belong to devices, so a clinic should name only what its own device is authorized for, use the word FDA's record uses ("cleared", or "granted" for a De Novo device), and never say "FDA-approved".

NIMH adds a caution worth repeating to patients: rTMS does not match the therapeutic effects of ECT, and it is not approved for youth under 15 years old. Honest limits build more trust than big claims, and they keep your ads approved.

What can a TMS ad say on Google and Meta?

It can describe the treatment and who it is for; it cannot suggest the viewer has a condition, use your own audience lists on Google, or claim more than your device is cleared for. We found no Google or Meta rule written for TMS itself, so the general health rules apply.

One edge case: if your clinic also treats drug or alcohol addiction, Google's addiction services rule and LegitScript certification apply to those ads. Google says nicotine addiction is out of scope of that rule. See the LegitScript guide.

Why do adults who need mental health care not get it?

Often for reasons clear marketing can address: cost, not knowing where to go and not finding a program they want. In 2025, 19.7 million adults had a major depressive episode, and about a third of them received no mental health treatment that year, according to SAMHSA's national survey.

For a TMS clinic, that points to the pages and ads that matter most: what a course of treatment costs and how coverage works, where you are and how to start, and what the room, the staff and a session actually look like.

How does a patient get from a search to a TMS chair?

Through five steps, and marketing has a job at each one: be found, answer the first call, check coverage, support the evaluation, and keep the patient informed through the course.

How does PELORA market a TMS clinic?

In the same order every time, starting with what your clinic is actually cleared and staffed to do.

1. Know the clinic first

   Your device and what it is cleared for, your psychiatrists, the plans you take, your hours and how many new patients you can start each week. Every ad and page is built from these facts.

2. Be the clear answer in search

   A page for each location and each cleared use, a complete Google Business Profile, and plain answers on cost, coverage and what a session is like, written so Google and AI answers can quote them.

3. Ads within the health rules

   Google search ads on what people type about TMS and depression treatment, with no remarketing lists; Meta ads that describe the treatment, never the viewer.

4. Information for referring clinicians

   We build pages and a one-page guide that tell psychiatrists, therapists and primary care doctors who TMS is for and how to refer; your team does the outreach. We never pay, or arrange payment, for referrals.

5. A coverage checklist for your intake team

   A written coverage checklist and plain answers your team can use on calls, and tracking set up with your counsel so no health details reach an ad platform.

6. Measure starts, not clicks

   Evaluations booked and treatment courses started, from your own counts, reported every month.

How much should a TMS clinic spend on marketing?

Start from what one patient's course of treatment is worth to the clinic, then work back to what you can pay to start one. Preston walks through that math in under two minutes, and our free calculator does it with your numbers (use its blank sheet for TMS). PELORA's own plans start at $3,500 a month, and ad spend is paid by you directly, never marked up.

1:51

How is this different from general clinic marketing?